Introduction
============

Ultrasound-mediated drug delivery
---------------------------------

Ultrasound has been investigated as a method for triggering enhanced drug delivery within the human vasculature. This technique is broadly appealing, given the potential of ultrasound to control drug delivery spatially and temporally in a noninvasive manner. Ultrasound-mediated drug delivery (UMDD) has been demonstrated in a number of tissue beds, including the blood--brain barrier, cardiac tissue, prostate, and large arteries.

Acoustic cavitation is a physical mechanism that is hypothesized to mediate UMDD.[@b1-ijn-9-4671]--[@b4-ijn-9-4671] Cavitation refers to nonlinear bubble activity that occurs within the vasculature upon ultrasound exposure and can exert mechanical stress on nearby cells and junctions. Mechanical stress can trigger the reduction of barriers to drug delivery, such as endothelial tight junctions or phospholipid membranes, via transient permeabilization. Cavitation can be nucleated at moderate peak-to-peak acoustic pressure amplitudes (\<1 MPa) by ultrasound contrast agents.[@b5-ijn-9-4671]--[@b8-ijn-9-4671]

Nitric oxide (NO) is a molecule that plays a mechanistic role in UMDD. A potent vasodilating gas, NO is involved in the regulation of paracellular and transcellular transport pathways,[@b1-ijn-9-4671],[@b9-ijn-9-4671] and is implicated as a regulatory promoter of hyperpermeability.[@b3-ijn-9-4671],[@b10-ijn-9-4671] Attenuation of NO production in the etiology of progression[@b5-ijn-9-4671],[@b11-ijn-9-4671] of atherosclerosis and diabetic vascular disease[@b1-ijn-9-4671],[@b2-ijn-9-4671],[@b12-ijn-9-4671]--[@b14-ijn-9-4671] further highlights the need for novel therapeutic NO modulation and delivery strategies.

Drug delivery quantification
----------------------------

Strategies to study ultrasound-mediated drug release and delivery in vitro and ex vivo have involved optical and electrophysiological techniques.[@b3-ijn-9-4671],[@b4-ijn-9-4671],[@b15-ijn-9-4671]--[@b19-ijn-9-4671] Optical techniques, such as fluorescence[@b16-ijn-9-4671],[@b20-ijn-9-4671],[@b21-ijn-9-4671] or luminescence,[@b18-ijn-9-4671],[@b22-ijn-9-4671],[@b23-ijn-9-4671] take advantage of the native optical properties of the therapeutic or conjugation of tracer molecules. Electrophysiological approaches, such as voltage-clamp techniques,[@b19-ijn-9-4671],[@b24-ijn-9-4671],[@b25-ijn-9-4671] directly assess the changes in membrane potential provoked during UMDD, but often require isolated cells cultured in vitro, where cellular processes can vary from in vivo conditions.[@b26-ijn-9-4671]--[@b28-ijn-9-4671] In vivo animal models of UMDD provide relevant bioeffect information, but are costly and subject to considerable intersubject variability. The ability to detect and monitor the response of intact, isolated vascular tissue in real time would constitute a significant advancement in the study of UMDD.

Isolated tissue bath perfusion systems have been used extensively to characterize contractility changes induced by a therapeutic[@b20-ijn-9-4671],[@b29-ijn-9-4671]--[@b33-ijn-9-4671] in a variety of muscular tissue beds, including gastric,[@b1-ijn-9-4671],[@b2-ijn-9-4671],[@b12-ijn-9-4671]--[@b14-ijn-9-4671] peripheral vascular,[@b3-ijn-9-4671],[@b4-ijn-9-4671],[@b15-ijn-9-4671]--[@b19-ijn-9-4671] and cardiovascular[@b16-ijn-9-4671],[@b20-ijn-9-4671],[@b21-ijn-9-4671] beds. In these systems, dose-dependent changes in active muscular tension can be characterized in response to vasorelaxing agents such as bradykinin,[@b18-ijn-9-4671],[@b22-ijn-9-4671],[@b23-ijn-9-4671] sodium nitroprusside,[@b19-ijn-9-4671],[@b24-ijn-9-4671],[@b25-ijn-9-4671] nitroglycerin,[@b26-ijn-9-4671]--[@b28-ijn-9-4671] and NO.[@b20-ijn-9-4671],[@b29-ijn-9-4671]--[@b33-ijn-9-4671] Adaptation of the isolated tissue bath model to drug delivery studies could provide relevant, real-time quantitative data on the drug release and delivery profiles triggered by ultrasound. We hypothesize that these isolated tissue bath systems can be used to characterize NO-mediated changes in carotid vascular tone upon ultrasound exposure.

Materials and methods
=====================

Tissue bath system
------------------

Due to their similarity to human arteries, ease of excision, and robust post mortem viability,[@b31-ijn-9-4671] porcine carotid arteries were chosen as the model artery to study NO delivery. Carotid arteries were obtained post mortem from young Yorkshire pigs (\~20 kg) according to a protocol approved by the Institutional Animal Care and Use Committee at the Cincinnati Department of Veterans Affairs Medical Center (Animal Welfare Assurance Number A3446-01). Seven pigs were initially anesthetized with intravenous ketamine 30 mg/kg, followed by pentobarbital 35 mg/kg for deep surgical anesthesia. Prior to artery excision, the animals were euthanized with saturated KCl solution (\~\[KCl\]~in\ vivo~ 0.18 M). Segments of porcine carotid tissue were harvested immediately following sacrifice and stored in ice-cold, oxygenated Krebs--Henseleit buffer (KHB, NaCl 115.9 mM; KCl 5.4 mM; MgSO~4~-7H~2~O 1.2 mM; NaHCO~3~ 25 mM; D-glucose 11.1 mM; NaH~2~PO~4~ 0.5 mM) until use within 18 hours of excision from the animal. Previous investigators[@b32-ijn-9-4671] have suggested that arteries remain viable for up to 3 days if obtained and handled in this manner. The tissue was dissected free of loose adventitia and connective tissue, and segmented into rings. These rings were cut to a length between 3.95 mM and 4.05 mM; the mean wet mass after blotting was 20.5 mg with a standard deviation of 2.6 mg. Each segment was mounted on two rigid, stainless-steel wires. The bottom wire was fixed to the tissue bath, and the top wire was coupled to an isometric force transducer (Radnoti LLC, Monrovia, CA, USA) for measurement of arterial tension. The electronic configuration is depicted in [Figure 1](#f1-ijn-9-4671){ref-type="fig"}. The tension signal was sampled digitally at 20 Hz (LabChart 6; AD Instruments, Colorado Springs, CO, USA) and saved to a PC for post-processing. The carotid segment was submerged in a custom reservoir filled with KHB maintained at physiologic temperature with continuous bubbling of a 95% O~2~/5% CO~2~ gas mixture to maintain physiologic pH (range 7.35--7.45).

Following mounting of the artery and submersion in physiologic KHB, healthy arteries underwent a brief contraction and relaxation cycle.[@b32-ijn-9-4671] Artery rings not exhibiting this behavior were deemed unfit for experimentation and discarded. Prior to treatment, the arterial ring was pre-stretched to relieve the passive elastic component of arterial tension in a manner similar to that described by Herlihy and Murphy.[@b32-ijn-9-4671] Briefly, the artery was stretched incrementally by translating the force transducer with a micropositioning stage (Radnoti LLC). To equilibrate the artery within physiologic buffer, the artery was alternately contracted and relaxed by serial infusions of KHB and KHB containing additional KCl, substituted in an equimolar fashion for NaCl. KCl was chosen as the optimal contractile agent in this biomedical engineering study due to its ability to induce rapid smooth muscle constriction consistently across carotid arteries excised from different pigs of the same breed. Each artery was contracted initially to steady state using KHB containing 50 mM KCl after each increment. Following a KHB wash, this process was repeated until a maximum KCl contraction was achieved. Healthy arteries consistently responded to precontraction with 50 mM KCl-doped KHB; however, the extent of precontraction was variable (range 200--330 mN). The basal ring tension that produced a maximum contraction tension was determined to be 75 mN. Thus, subsequent rings were manually prestretched to this basal tension upon mounting.

Bubble liposomes
----------------

Bubble liposomes were manufactured according to the method described by Endo-Takahashi et al[@b34-ijn-9-4671] for bubble liposomes. This liposomal formulation consisted of dipalmitoylphosphatidylcholine (DPPC), N-\[1-(2,3-dioleoyloxy) propyl\]-N,N,N-trimethylammonium (DOTAP), polyethylene glycol (PEG) 2000, and PEG 750 in a 79:15:3:3 molar ratio. After manufacturing, 1 mL (1 mg lipid) of the liposomal emulsion was pipetted into glass vials, which were evacuated of headspace air with a laboratory vacuum and stored at 4°C until use. Immediately prior to use, the vials were warmed to room temperature and 2.5 mL of gas was injected into the vial headspace through a rubber septum. For NO-loaded bubble liposomes (NOBLs), this gas consisted of a 50:50 volume ratio of NO gas (Sigma-Aldrich, St Louis, MO, USA) and octafluoropropane (C~3~F~8~, or OFP) gas (Specialty Gases of America, Toledo, OH, USA). To assess the effect of cavitation alone (without NO) on vasorelaxation, C~3~F~8~ bubble liposomes were also manufactured by injecting 2.5 mL of C~3~F~8~. Following this step, the vial was mechanically agitated by shaking vigorously for 45 seconds (Vialmix^®^, Lantheus Medical Imaging, North Billerica, MA, USA). This agitation step heated the emulsion slightly, so the vial was allowed to equilibrate to room temperature. Immediately prior to experimental use, 500 μL of the liposomal emulsion was diluted into oxygenated (pO~2~: 722 mmHg) room temperature KHB to a final concentration of 0.05 mg lipid/mL for infusion into the system.

NOBL characterization
---------------------

A sample of the NOBL suspension was diluted (1:1000; v/v) into room temperature, aerated phosphate-buffered saline (Sigma-Aldrich) and the size distribution was measured using an impedance-based particle sizer (Multisizer 4, 30 μm aperture; Beckman Coulter, Brea, CA, USA). Each measurement analyzed 100 μL of the diluted sample through a 30 μm aperture over 30 seconds. Each measurement produced a number density histogram, corrected for the dilution, with bins logarithmically spaced between 0.6 μm and 18 μm. This histogram was transformed into a volume-weighted distribution for further analysis. The results from three measurements, each using a fresh vial of NOBLs, were averaged to produce a final volume-weighted size distribution.

The frequency-dependent attenuation coefficient, α(f) in dB/cm, was determined using a broadband substitution technique,[@b35-ijn-9-4671] the components of which were described previously in Raymond et al.[@b36-ijn-9-4671] Briefly, NOBLs were diluted (1:500) into a reservoir containing aerated phosphate-buffered saline, stirred, and allowed to flow by gravity into a sample chamber with acoustically transparent polycarbonate film windows (CLINIcell 25, Mabio, Tourcoing, France). The reservoir, sample chamber, and transducers were mounted in a test tank filled with distilled water maintained at 37°C±0.5°C using a circulating water bath (Neslab EX, Newington, NH, USA). A pair of broadband transducers (PI-20, Olympus NDT, Waltham, MA, USA) was used to acquire the through-transmission spectrum over the frequency range of 1--30 MHz (31 KPa peak negative pulse pressure; 33 dB dynamic range). The attenuation spectrum was computed from the received amplitude spectra in the absence (diluent alone) and presence of the bubble liposomes, respectively. Acoustic attenuation measurements were made in triplicate and a separate vial of NOBLs was used for each measurement.

Hemoglobin
----------

The short half-life (\<1 second) of NO in the presence of hemoglobin and oxygen in vivo limits the spatial extent over which NO can be effective as a signaling molecule.[@b37-ijn-9-4671] In order to mimic the in vivo milieu more closely and to quench nonencapsulated NO, 1 g/L hemoglobin (porcine, Sigma-Aldrich) was added to the reservoir prior to each treatment. We observed that hemoglobin concentrations greater than 1 g/L produced a negligible decrease in vasorelaxation during NOBL + KHB infusions and occasionally caused vasospasmic contractions. Thus, 1 g/L hemoglobin was used in all subsequent treatments.

Ultrasound exposure and cavitation detection
--------------------------------------------

To reveal the mechanism of ultrasound-mediated drug release and delivery of NO to vascular tissue, two ultrasound transducers were coupled to the tissue bath reservoir. One transducer was used to deliver pulsed ultrasound to nucleate cavitation from the liposomes and a second transducer was used to monitor the acoustic emissions passively for evidence of acoustic cavitation. The experimental configuration is depicted in [Figure 1](#f1-ijn-9-4671){ref-type="fig"}. Prior to each experiment, a calibrated 1 MHz therapy transducer (Olympus Panametrics, Waltham, MA, USA) was aligned confocally with a 7.5 MHz passive cavitation detector (PCD; Olympus Panametrics) using an ultrasonic pulser receiver (5077PR; Olympus NDT). The confocal point was positioned in the axial center of the carotid ring using a three-axis translation stage (Newport 423, Irvine, CA, USA). This geometry was chosen to ensure that the ultrasound therapy field encompassed the entire carotid artery, while cavitation emissions were detected primarily from the lumen. During experimental treatment, a function generator (Agilent Technologies, Santa Clara, CA, USA) supplied a sinusoidal signal (30 cycles, 100 Hz pulse repetition frequency) that was amplified (750A250; Amplifier Research, Souderton, PA, USA) and used to drive the 1 MHz therapy transducer. Acoustic scattering within the tissue bath reservoir affected the beam profile slightly. Therefore, an in situ pressure field calibration was performed in the absence of the artery ring and wires ([Figure 2](#f2-ijn-9-4671){ref-type="fig"}).

During ultrasound exposure, acoustic emissions were detected by the PCD, high-pass filtered (1 MHz high-pass, \#07766 TTE, Los Angeles, CA, USA), amplified (10×, Model 5185, Signal Recovery, Oak Ridge, TN, USA), and sampled at 20 MHz with an oscilloscope (LeCroy Model LT372, Chestnut Ridge, NY, USA). Sequences of 128 voltage time traces were saved to a PC for post-processing ([Figure 3A](#f3-ijn-9-4671){ref-type="fig"}). To enable cavitation detection spaced more consistently in time, one of every four pulses was saved. The traces were analyzed using a custom MatLab (The Mathworks Inc, Natick, MA, USA) script to extract spectral information associated with specific modes of bubble activity. A window (Blackman window, MatLab) was applied to each scattered pulse ([Figure 3B](#f3-ijn-9-4671){ref-type="fig"}) and transformed into the frequency domain. Each frequency spectrum was scaled to account for the energy lost due to windowing. A frequency domain comb filter was applied to the power spectrum ([Figure 3C](#f3-ijn-9-4671){ref-type="fig"}) to extract the ultraharmonic (100 kHz bands at odd multiples of 500 kHz) and broadband (50 kHz bands between harmonic and ultraharmonic frequencies) components of the spectrum. The energy contained in the ultraharmonic and broadband signals was associated with stable and inertial cavitation, respectively.[@b38-ijn-9-4671],[@b39-ijn-9-4671] This process is depicted graphically in [Figure 3](#f3-ijn-9-4671){ref-type="fig"}.

Ultrasound parameters were chosen to promote stable cavitation nucleated by the NOBLs within the lumen of the arterial ring over the 55-second treatment. A 30-cycle therapy pulse was chosen to minimize standing waves in the reservoir. To determine the optimal acoustic pressure to promote stable cavitation, a dose-escalation approach was employed. An artery was mounted within the reservoir filled with oxygenated KHB containing 1 g/L hemoglobin. NOBL infusions (0.2 mL/min) with concurrent ultrasound exposure and cavitation detection were performed serially. Between each treatment, the reservoir was flushed with fresh hemoglobin-doped KHB and the acoustic pressure increased incrementally. This process was repeated at peak-to-peak acoustic pressure amplitudes ranging from 0 MPa to 0.38 MPa. The peak-to-peak acoustic pressure amplitude that promoted maximal ultraharmonic energy over the 50-second ultrasound exposure (0.34 MPa) was chosen for all subsequent exposures.

Treatment
---------

During treatment, the lumen of each artery was infused for 55 seconds with randomized combinations of buffer alone, buffer with NOBLs, or buffer with 12 μM sodium nitroprusside (Sigma-Aldrich) using a 24-gauge blunt hypodermic needle connected to a syringe pump (KD Scientific, \#23; Canning Vale, Australia). After 5 seconds of infusion, ultrasound or sham exposure and cavitation detection commenced. This experimental procedure is diagrammed in [Figure 4](#f4-ijn-9-4671){ref-type="fig"}.

Tension analysis
----------------

Arterial ring tension was analyzed using a custom MatLab script. Each tension curve was normalized to the maximum tension produced by 50 mM KCl KHB using [Equation 1](#fd1-ijn-9-4671){ref-type="disp-formula"}, $$\text{\%\ Relaxation} = \frac{T_{\mathit{MAX}} - T(t)}{T_{\mathit{MAX}} - T_{\mathit{BASAL}}}$$where *T~MAX~* is the initial tension produced by KCl contraction, *T*(*t*) is the arterial tension as a function of time, and *TBASAL* is the basal tension after manual stretching (75 mN). A representative tension curve for each treatment is given in [Figure 5](#f5-ijn-9-4671){ref-type="fig"}. For each treatment, the minimum value percent relaxation, ie, maximal relaxation, was used to compare across treatment groups. This metric has been used previously to compare treatments in NO-related vascular tension studies.[@b40-ijn-9-4671]

Statistical analyses
--------------------

In general, the mean and standard deviation of each data set was reported. Statistical analyses were performed using MatLab (Statistical Toolbox). Normal distributions were confirmed using Lilliefors test, with a threshold *P*-value of 0.05. Differences in means between treatment groups were analyzed using a one-way unbalanced analysis of variance. *P*-values less than 0.05 were considered to be statistically significant. Subsequently, pairwise comparisons with a Bonferroni correction were performed to compare across individual treatments to minimize the family-wise error rate for multiple comparisons.

Linear regression was performed to test for a correlation between maximal relaxation and (a) wet tissue weight, (b) 35 mM KCl tension, and (c) cavitation energy. A one-way unbalanced analysis of variance was used to test for significant correlations. For these tests, the *P*-value, f-statistic (F~stat~), and degrees of freedom (df) are reported. Spearman's rank correlation coefficients (*ρ*) were computed to test for monotonic statistical relationships. The null hypothesis of no correlation was tested to produce a *P*-value; values below 0.05 were considered to be statistically significant.

Results
=======

Liposome characterization
-------------------------

As depicted in [Figure 6A](#f6-ijn-9-4671){ref-type="fig"}, NOBLs had a broad, bimodal volume-weighted size distribution, ranging in diameter from approximately 1.5 μm to 15 μm. The peak volume density occurred at a diameter of 2.5 μm. A separate population of particles existed at 11 μm, diminishing in diameter above 15 μm.

[Figure 6B](#f6-ijn-9-4671){ref-type="fig"} shows the measured attenuation coefficient as a function of frequency for NOBLs (n=3). NOBLs attenuated ultrasound across the 33 dB bandwidth of the system (1--30 MHz). A strong, broad resonance peak (α =13.0 dB/cm) was observed at 5 MHz. A second resonance peak (α =12.3 dB/cm) was observed near 28 MHz. NOBLs attenuated weakly between these two frequencies.

Cavitation
----------

In general, ultraharmonic and broadband acoustic emissions within the arterial lumen persisted throughout the 50-second exposures in all eight ultrasound-treated arteries. [Figures 7A and B](#f7-ijn-9-4671){ref-type="fig"} show representative traces of the ultraharmonic and broadband acoustic power detected by the PCD as a function of time. A representative spectrum, averaged over the 55-second treatment, is depicted in [Figure 3C](#f3-ijn-9-4671){ref-type="fig"}. Ultraharmonic energy was typically strong, yet variable, during the first few seconds of ultrasound exposure, and remained steady for the duration of the 50-second exposure. Within the NOBL + ultrasound treatment group, no correlation was observed between maximal relaxation and the average spectral emissions (ultraharmonic, *ρ*=−0.45, *P*=0.21; harmonic, *ρ*=−0.46, *P*=0.25; broadband, *ρ*=−0.50, *P*=0.21).

Vasorelaxation
--------------

Seven carotid rings each from seven separate pigs were exposed to each experimental treatment, as shown in [Figure 8](#f8-ijn-9-4671){ref-type="fig"}. Carotid rings relaxed in response to treatments in a characteristic manner, ie, a sharp tension decrease followed by steady restoration to the tension level induced by 35 mM KCl precontraction. Neither the order of treatment nor the time post-excision from the animal (*ρ*=−0.45, *P*=0.21) resulted in an apparent trend in maximal relaxation. Relaxation after 12 μM sodium nitroprusside infusions was significantly stronger (32%±5%) than NOBL infusions (*P*\<0.01, F~stat~ =104.15, df =13) and sham control treatments, which consisted of buffer and NOBLs (7%±3%), buffer and ultrasound (1%±2%), or C~3~F~8~ bubble liposomes and ultrasound exposure (2%±1%). Arterial rings exposed to NOBLs + ultrasound experienced strong maximal relaxation (31%±8%) that was significantly greater than buffer and NOBLs (*P*\<0.001, F~stat~ =29.01, df =13) and statistically identical to treatment with 12 μM sodium nitroprusside (*P*=0.18, Fstat =2.06, df =13). Across all experimental samples, no correlation was observed between the maximal relaxation and precontraction tension (*P*=0.82, F~stat~ =0.05, df =21) or wet tissue weight (*P*=0.33, F~stat~ =0.98, df =21).

Discussion
==========

Liposome characterization
-------------------------

The characteristics of NOBLs can be compared directly with previously reported data on C~3~F~8~-loaded bubble liposomes manufactured using similar methods. Endo-Takahashi et al[@b34-ijn-9-4671] reported a volume-weighted size distribution peak at 749 nm with a significant volume-weighted population greater than 4 μm. The bubble liposomes of Endo-Takahashi et al[@b34-ijn-9-4671] containing only C~3~F~8~, are smaller than the NOBLs described in this study ([Figure 6A](#f6-ijn-9-4671){ref-type="fig"}). NOBLs have a bimodal volume-weighted size distribution with a primary peak at 2.5 μm and variable, secondary peak at 11 μm. This size distribution has implications for clinical translation: nanosized NOBLs are small enough to pass through the pulmonary capillary bed[@b41-ijn-9-4671] yet large enough to permit strong cavitation nucleation from 1 MHz ultrasound exposure.[@b7-ijn-9-4671] In future studies, subpopulations of the bimodal distribution could be isolated by differential centrifugation[@b42-ijn-9-4671] to avoid undesired retention in micron-sized capillaries. However, these techniques present a trade-off between frequency-dependent ultrasound response and drug-loading capability, which are both highly dependent on particle size.[@b43-ijn-9-4671]

The size discrepancy between the primary peaks could be explained by the use of a NO/C~3~F~8~ blend in this study, compared with C~3~F~8~ alone used in the report by Endo-Takahashi et al.[@b34-ijn-9-4671] NO is more soluble in lipid than in aqueous solution,[@b44-ijn-9-4671] yet reacts more readily with oxygen in these environments. NO is further soluble in perfluorocarbon, demonstrated by prolonged release profiles in an in vivo hamster model.[@b45-ijn-9-4671] In this study, efforts were made to ensure that the procedure used to manufacture NO/octafluoropropane-loaded liposomes mimicked closely the procedure outlined by Endo-Takahashi et al.[@b34-ijn-9-4671] Kim et al describe an alternative method to encapsulate NO within echogenic liposomes which minimizes oxidation and degradation of NO prior to experimental use.[@b46-ijn-9-4671] Future work should implement these procedures and tailor the gas and lipid composition in NOBL formulations to achieve an optimal release profile and size distribution to improve therapeutic benefit.

Using this liposomal formulation, the pharmacokinetics of NOBLs in vivo are unclear. The peak number density of NOBLs occurred at 600 nm, which was the lower limit of size detection used here. Particles in this size range, capable of retention within tumor vasculature,[@b47-ijn-9-4671] can effectively attenuate ultrasound at theragnostic frequencies.[@b48-ijn-9-4671] Further, DOTAP, a cationic lipid, likely conferred an affinity to the anionic endothelial glycocalyx.[@b49-ijn-9-4671] This strong affinity for the vascular walls would decrease circulation time in vivo,[@b50-ijn-9-4671] possibly necessitating local infusion, which would limit the applicability of NOBLs to tissues downstream from traditional intra-arterial access sites. Enhanced targeting and localization near the endothelium could also be achieved ultrasonically by use of acoustic pulses to optimize radiation force[@b51-ijn-9-4671] and acoustic streaming.[@b52-ijn-9-4671] The presence of long chain (PEG 2000) and short chain (PEG 500) polyethylene glycol has been used in liposomal formulations to mitigate potential immunogenicity and antigenicity, thus prolonging circulation time.[@b53-ijn-9-4671] In our model, bubble liposomes were injected directly into the lumen of the arterial ring, where they were exposed to 30 cycle pulses of 1 MHz ultrasound at a peak-to-peak acoustic pressure amplitude of 0.34 MPa. Hemoglobin at in vivo concentrations would completely quench NO produced within the lumen of a blood vessel, thus necessitating NO delivery in close proximity to the endothelium.[@b15-ijn-9-4671],[@b54-ijn-9-4671] Future studies investigating ultrasound-mediated NO release from liposomes should consider these issues.

Ultrasound exposure and cavitation
----------------------------------

The data presented here demonstrate that strong relaxation by NO-loaded liposomes can be enhanced by ultrasound exposure at acoustic pressures lower than previously described.[@b46-ijn-9-4671],[@b55-ijn-9-4671] In this study, vascular relaxation was triggered from NOBLs with pulsed ultrasound at a peak-to-peak acoustic pressure amplitude of 0.34 MPa. Despite the detection of strong cavitation at this acoustic pressure, the precise mechanism of NO release and delivery remains unclear. Smith et al describe acoustically driven diffusion at moderate acoustic pressures,[@b56-ijn-9-4671],[@b57-ijn-9-4671] and other investigators[@b7-ijn-9-4671],[@b58-ijn-9-4671],[@b59-ijn-9-4671] have postulated that the lipid shell of microbubbles must first be ruptured before cavitation nucleation can occur, liberating encapsulated gas during rapid fragmentation. At a 0.34 MPa pressure exposure, it is likely that NO was released from the bubble liposomes gradually over a number of acoustic cycles. Radhakrishnan et al[@b60-ijn-9-4671] have detected loss of echogenicity from contrast agents at acoustic pressures below the stable and inertial cavitation thresholds. In their experiments using Definity^®^ and echogenic liposomes, the onset of stable and inertial cavitation was concomitant with an 80% loss of echogenicity. Thus, the release of NO from bubble liposomes could also occur at acoustic peak-to-peak pressures lower than the 0.34 MPa utilized in the present study. The minimum pressure amplitude that triggers the delivery of NO to vascular tissue warrants further elucidation.

In this study, C~3~F~8~ stabilized NO within the bubble liposomes prior to activation by ultrasound. The different properties of these gases (eg, molecular size, solubility) could promote a differential diffusion profile during acoustically driven oscillation. Upon membrane distention during volumetric bubble expansion, NO would likely dissolve more readily in the surrounding aqueous medium due to its high solubility. Also, after liberation of NO, the residual C~3~F~8~ bubble activity could promote microstreaming and enhanced convection and penetration into nearby vascular tissue. The diffusivity of NO, roughly 3,300 μm^2^ per second in muscular tissue,[@b24-ijn-9-4671],[@b54-ijn-9-4671],[@b61-ijn-9-4671] is high enough to support a linear diffusion distance of roughly 250 μm (approximate radial depth of porcine carotid smooth muscle cells[@b11-ijn-9-4671],[@b62-ijn-9-4671]) over several seconds. NOBL infusions with ultrasound exposure consistently caused sharp decreases in vascular tension, typically occurring in the order of tens of seconds, followed by a steady tension restoration period, which lasted several minutes ([Figure 5](#f5-ijn-9-4671){ref-type="fig"}).

Vasorelaxation
--------------

Arterial segments relaxed significantly more when treated with NOBL infusions in the presence of pulsed ultrasound, compared with infusions with NOBLs alone ([Figure 8](#f8-ijn-9-4671){ref-type="fig"}). The ability of ultrasound to promote the delivery of encapsulated NO to vascular tissue agrees with observations by previous investigators.[@b46-ijn-9-4671],[@b63-ijn-9-4671],[@b64-ijn-9-4671] Kim et al[@b46-ijn-9-4671] using NO-loaded echogenic liposomes, demonstrated increased vasodilation of rabbit carotids after exposure to 5.7 MHz color Doppler ultrasound at a peak negative acoustic pressure of 0.35 MPa. Huang et al used a mixture of NO and argon gas to encapsulate NO and trigger effective release to porcine carotid tissue.[@b55-ijn-9-4671] In this study, the release of NO from the liposome into the surrounding medium was decreased by roughly 65% using the argon/NO mixture. At lower peak-to-peak pressure amplitudes (\<0.40 MPa), other encapsulated bioactive gases, such as xenon, have been shown to exhibit enhanced release and delivery profiles with ultrasound.[@b16-ijn-9-4671],[@b56-ijn-9-4671],[@b65-ijn-9-4671] Other studies have demonstrated the feasibility of encapsulating NO or NO-yielding molecules to prevent physiologic degradation.[@b58-ijn-9-4671],[@b66-ijn-9-4671] For example, McKinlay et al demonstrated strong vasorelaxation of porcine coronary rings incubated with NO bound within a porous organic metal framework.[@b58-ijn-9-4671] Consequently, future studies should focus on elucidating the mechanisms of NO release from NOBLs, so that efficient exposure protocols can be developed to translate ultrasound-mediated NO delivery into the clinic.

System development
------------------

Although the ultrasound tissue bath system is capable of providing real-time feedback on NO delivery to vascular tissue, it has a few limitations. Here, a volatile anesthetic was used to sedate the animals prior to carotid excision, which can reduce endothelium function significantly by inhibiting endothelial production of NO.[@b12-ijn-9-4671],[@b24-ijn-9-4671] Cavitation near the vascular endothelium during UMDD[@b11-ijn-9-4671],[@b14-ijn-9-4671],[@b67-ijn-9-4671] is hypothesized to liberate endothelial NO synthase from membrane-bound proteins, such as caveolin-1.[@b46-ijn-9-4671],[@b63-ijn-9-4671],[@b64-ijn-9-4671] Increased cytosolic endothelial NO synthase results in increased endothelium-derived NO,[@b10-ijn-9-4671],[@b68-ijn-9-4671] an effect likely absent in our model. Future studies should employ sedatives that do not adversely affect endothelial response, or should use abattoir-derived vascular tissue.

During arterial precontraction, porcine hemoglobin was diluted into the reservoir to a concentration of 1 g/L. At this concentration, arteries consistently re-established equilibrium contraction tension following NO-induced vasorelaxation. This was likely due to the quenching of excess NO by hemoglobin, a reaction well documented in vivo.[@b16-ijn-9-4671],[@b40-ijn-9-4671],[@b65-ijn-9-4671] Because free hemoglobin quenches NO a thousand times faster than hemoglobin within intact erythrocytes,[@b60-ijn-9-4671],[@b69-ijn-9-4671] the presence of free hemoglobin in the bath likely resulted in a weaker vasorelaxation than expected in vivo in the absence of hemolysis.

At higher hemoglobin concentrations (\>40 g/L) or in whole blood (120 g/L[@b31-ijn-9-4671],[@b40-ijn-9-4671]), arteries routinely experienced periodic contractions that prevented restoration of tension to equilibrium. This effect was likely indicative of vasospasm, which has been documented in cerebral arteries as a result of subarachnoid hemorrhage.[@b12-ijn-9-4671] While this effect was a limitation in our model, Fathi et al[@b67-ijn-9-4671] describe a potential role of NO delivery to treat cerebral tissue following subarachnoid hemorrhage. Also, using intact erythrocytes, Kim et al describe a technique to release NO from loaded echo-genic liposomes within the rabbit carotid artery to reduce ischemic neurologic deficits.[@b46-ijn-9-4671] Intact, fresh erythrocytes also ensure the presence of viable oxyhemoglobin to bind NO efficiently.[@b68-ijn-9-4671] Future applications of this ultrasound tissue bath model should implement hemoglobin in the form of intact erythrocytes to ease the transition to possible clinical applications, such as localized ultrasound-mediated delivery of NO for arresting development of atheroma,[@b1-ijn-9-4671],[@b4-ijn-9-4671],[@b13-ijn-9-4671] induction of vascular hyperpermeability,[@b1-ijn-9-4671],[@b3-ijn-9-4671] or treatment of vasospasm after subarachnoid hemorrhage.[@b68-ijn-9-4671]

The system described here also implemented an infusion of treatment combinations directly to the lumen of the vessel. This approach, while likely difficult to replicate in vivo, ensured steady replenishment of drugs and bubbles during experimental treatment, and permitted simple adaptation of a previously established tissue perfusion model. An infusion of 12 μM sodium nitroprusside, directly infused into the lumen of the artery, likely only remained in the arterial lumen for a few seconds before being dispersed throughout the large reservoir filled with Krebs buffer. Together, these changes may have resulted in a much lower amount of sodium nitroprusside, and its product NO, delivered to the vascular rings compared with preparations using sodium nitroprusside in traditional tissue bath systems.

Smooth muscle relaxation
------------------------

In vivo, NO-mediated modulation of smooth muscle tone is well described by two biochemical pathways: (a) stimulation of guanosine 3′:5′ cyclic monophosphate (cGMP) and adenosine 3′:5′ cyclic monophosphate and (b) direct modulation of calcium-activated, potassium channel (K^+^~Ca~) permeability.[@b40-ijn-9-4671] Bolotina et al describe the effect of exogenous NO on cGMP and K^+^~Ca~. These authors observed that cGMP-mediated vasorelaxations from exposure to NO were transient in nature and concentration-dependent, as determined by quantifying maximal relaxation,[@b69-ijn-9-4671] which is the metric used here. According to Tare et al the K^+^~Ca~ pathway can affect the temporal nature of NO-mediated vasorelaxation, an interesting future application of this novel system. Accordingly, these authors integrated vasorelaxation over time to quantify integrated relaxation.[@b40-ijn-9-4671] Due to the potential for sensitivity to the K^+^~Ca~-dependent pathway of NO-mediated vasorelaxation, integrated relaxation could be considered as a potential metric in future applications of this system, and may assist in understanding the temporal nature of ultrasound-mediated NO release from bubble liposomes.

Conclusion
==========

The ultrasound tissue bath system described here demonstrates a novel, effective technique to characterize ultrasound-mediated delivery of a bioactive gas to vascular tissue. Ultrasound tissue bath systems can be used to monitor UMDD in real time. The data presented demonstrate that NO can be released from bubble liposomes with 1 MHz pulsed ultrasound exposure and deposited into vascular tissue. NO penetration into tissue causes potent vasorelaxation, which manifests as a change in isometric vascular tension. Future studies using this technique may focus on monitoring the delivery of other bioactive agents that cause vasorelaxation, such as proteins, cells, or nucleic material.
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![Electronic configuration of the ultrasound tissue bath system.\
**Notes:** Two submersible ultrasound transducers are coupled to the reservoir: a transmit transducer (1 MHz, 3% duty cycle, blue) focuses on the lumen of the artery, while a second receive transducer (7 MHz, orange) detects cavitation emissions from nitric oxide-loaded bubble liposomes perfused within the vessel lumen (red) via a 26-gauge blunt injection needle.\
**Abbreviation:** US, ultrasound.](ijn-9-4671Fig1){#f1-ijn-9-4671}

![In situ ultrasound beam profiles of the 1 MHz and 7.5 MHz transducers.\
**Notes:** The --3 dB contours of the transmit field (blue) and receive sensitivity (orange) are depicted, along with the anticipated location of the artery (red, box).](ijn-9-4671Fig2){#f2-ijn-9-4671}

![Graphical representation of the signal processing technique used to assess cavitation emissions detected by the single element passive cavitation detector.\
**Notes:** (**A**) Scattered pulses detected by the passive cavitation detector were filtered (1 MHz low pass filter), amplified (10×), digitized, and saved to a PC in sequence mode. Individual pulses were windowed in the time domain (**B**), and then transformed into the frequency domain. Ultraharmonic and broadband components of the power spectrum (**C**) were quantified, and served as indicators of stable and inertial cavitation, respectively.](ijn-9-4671Fig3){#f3-ijn-9-4671}

![Timeline of procedures performed during a typical experimental exposure.\
**Notes:** Repeated measurements were made in series following 35 mM potassium chloride washes, followed by tension equilibration.](ijn-9-4671Fig4){#f4-ijn-9-4671}

![Representative tension reduction (relative to the maximum KCl contraction tension) for buffer + US, buffer + NOBLs, NOBLs + US (peak-to-peak acoustic pressure amplitude 0.34 MPa), and control agonist sodium nitroprusside. Each treatment's minimum tension (maximal relaxation) was used for grouped analysis.\
**Abbreviations:** SNP, sodium nitroprusside; NOBLs, nitric-oxide loaded bubble liposomes; US, ultrasound.](ijn-9-4671Fig5){#f5-ijn-9-4671}

![**(A)** Size distribution (n=3) of the NOBLs, weighted by volume (black) and number density (gray).\
**Notes:** The presence of particles \>4 μM (by volume) agrees with Endo-Takahashi et al.[@b34-ijn-9-4671] Dots indicate one standard deviation. (**B**) Acoustic attenuation as a function of frequency, as determined using the system described in Raymond et al.[@b36-ijn-9-4671]](ijn-9-4671Fig6){#f6-ijn-9-4671}

![Spectral analysis of scattered acoustic signal from NOBLs.\
**Notes:** Averaged spectrum of detected cavitation emissions across a 50-second ultrasound exposure during NOBL infusion into the lumen of a carotid artery (solid), compared to spectral emission from sham ultrasound exposures (buffer + ultrasound alone, dotted). (**A**) Ultraharmonic (eg, 3f/2, 5f/2.) and (**B**) broadband frequency components of the transmitted fundamental frequency (f, 1 MHz) were consistently observed, indicating strong, persistent nonlinear bubble activity. Black circles indicate the mean of the local data group, bars indicate ± one standard deviation.\
**Abbreviation:** NOBLs, nitric oxide-loaded bubble liposomes.](ijn-9-4671Fig7){#f7-ijn-9-4671}

![Carotid artery vasorelaxation as a function of treatment.\
**Notes:** Data means are indicated by horizontal dotted lines and boxes indicate the 25th and 75th percentiles. The range of adjacent data is indicated by error bars. Seven arterial rings from seven pigs were used for all treatments. Statistically significant differences in data means (*P*\<0.05) were observed between all data sets except (**A**) buffer + US/buffer + OFPBL and (**B**) NOBLs + US/SNP.\
**Abbreviations:** SNP, 12 μM sodium nitroprusside; US, ultrasound; NOBLs, nitric-oxide loaded bubble liposomes; OFPBL, octafluoropropane-loaded bubble liposomes.](ijn-9-4671Fig8){#f8-ijn-9-4671}
